Andrew Dreyfus

Insider Reports History

Entity
Individual
Location
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA
Signature
/s/ Brian Tessler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Dreyfus:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IRONWOOD PHARMACEUTICALS INC Director Class A Common Stock 188K $1.18M $6.29 Jun 18, 2024 Direct
Alto Neuroscience, Inc. Director Stock Option (right to buy) 30.6K Feb 1, 2024 Direct

Insider Reports Filed by Andrew Dreyfus

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRWD IRONWOOD PHARMACEUTICALS INC Jun 18, 2024 1 $0 4 Jun 21, 2024 Director
ANRO Alto Neuroscience, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 Director
ANRO Alto Neuroscience, Inc. Feb 1, 2024 0 $0 3 Feb 1, 2024 Director
IRWD IRONWOOD PHARMACEUTICALS INC Jun 20, 2023 1 $0 4 Jun 22, 2023 Director
IRWD IRONWOOD PHARMACEUTICALS INC Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
IRWD IRONWOOD PHARMACEUTICALS INC Dec 15, 2021 1 $0 4 Dec 17, 2021 Director
IRWD IRONWOOD PHARMACEUTICALS INC Sep 15, 2021 1 $0 4 Sep 17, 2021 Director
IRWD IRONWOOD PHARMACEUTICALS INC Jun 15, 2021 1 $0 4 Jun 16, 2021 Director
IRWD IRONWOOD PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 4, 2021 Director